The TaqPath COVID-19 CE-IVD RT-PCR Kit contains assays, controls, and master mix required for the real-time PCR detection of RNA from the SARS-CoV-2 virus.Key features:- Detection using real-time PCR to diagnostic report generation in under 2 hours- Assays cover all of the SARS-CoV2 genomes of high sequence quality and complete sequence length that are currently available through the GISAID Initiative- Assays target genomic regions of the SARS-CoV-2 genome that are not present in other coronaviruses (e.g., SARS, MERS, bat SARS-like coronavirus, etc.)- COVID-19 Interpretive Software, which automatically converts genetic analysis data into diagnosis, helping reduce risk of user interpretation errorThe kit can be used by clinical and public health laboratories to quickly evaluate up to 382 patient specimens in under 2 hours. The kit contains the reagents and controls for a real-time reverse transcription polymerase chain reaction (RT-PCR) test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens (such as nasopharyngeal, oropharyngeal, nasal, and mid‑turbinate swabs, and nasopharyngeal aspirate) and bronchoalveolar lavage (BAL) specimens from individuals suspected of COVID-19.The TaqPath COVID-19 CE-IVD RT-PCR kit is a single, high throughput (1,000 reactions) kit and is approved for use on Applied Biosystems real-time PCR systems